Stockwinners Market Radar for March 15, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

TSVT

Hot Stocks

19:00 EDT 2seventy bio trading resumes
BMY TSVT

Hot Stocks

18:30 EDT Bristol Myers, 2seventy Bio: FDA's ODAC votes in favor of Abecma - Bristol Myers Squibb (BMY) and 2seventy bio (TSVT) announced that the U.S. FDA Oncologic Drugs Advisory Committee voted positively (8-3) that Abecma demonstrated a favorable benefit/risk profile for patients with triple-class exposed relapsed or refractory multiple myeloma based on results from the pivotal Phase 3 KarMMa-3 study, including the key secondary endpoint of overall survival. The recommendation from the ODAC will be considered by the FDA during its ongoing review of the supplemental Biologics License Application for Abecma for this patient population. The FDA has not yet assigned a new target action date for review of the sBLA.
BCO

Hot Stocks

17:01 EDT Brink's exec Bossart sells 10,000 common shares - In a regulatory filing, Brink's executive VP Dominik Bossart disclosed the sale of 10,000 common shares of the company on March 13 at a price of $84.96 per share.
DIT

Hot Stocks

16:51 EDT Amcon Distributing acquires Burklund Distributors, terms not disclosed - Amcon Distributing is pleased to announce the acquisition of Burklund Distributors of East Peoria, Illinois. Amcon will continue to serve Burklund customers from Burklund's East Peoria and Fairview Heights, Illinois distribution centers. Upon completion of this acquisition Amcon will be servicing approximately 7,400 locations in 32 states. The transaction is expected to close in the company's third quarter of fiscal 2024, subject to customary closing conditions.
TJX

Hot Stocks

16:42 EDT TJX CEO Herrman sells 20,304 common shares - In a regulatory filing, TJX Companies president and CEO Ernie Herrman disclosed the sale of 20,304 common shares of the company on March 13 at a price of $97.5741 per share.
NSC

Hot Stocks

16:34 EDT Norfolk Southern appoints corporate communications, compliance leaders - Norfolk Southern announced Wednesday that it has appointed Betsy Talton-Buck as vice president and chief communications officer, and Angie Kolar as vice president and chief compliance officer. Both appointments are effective April 9, and will report to Executive Vice President Corporate Affairs and Chief Legal Officer Nabanita Nag.
HTZ...

Hot Stocks

16:32 EDT Hertz CEO Stephen Scherr steps down, Gil West to succeed - Hertz Global Holdings (HTZ) announced that Gil West, former COO of Delta Airlines (DAL) and GM's (GM) Cruise unit, will become CEO effective April 1, at which time he will join the Board. West will succeed Stephen Scherr, who has decided to step down as CEO and member of the Board of Directors on March 31. West and Scherr will work together over the next several weeks to ensure a smooth transition.
DO

Hot Stocks

16:29 EDT Diamond Offshore sees $33M-$35M impact from Ocean GreatWhite incident in 1H24 - In a regulatory filing, the company stated, "As previously reported, on February 1, 2024, the Ocean GreatWhite, a semisubmersible drilling rig owned by a subsidiary of Diamond Offshore Drilling, reported that the rig's lower marine riser package and deployed riser string unintentionally separated from the rig at the slip joint tensioner ring and the LMRP and riser dropped to the seabed while located approximately 200 km to the west of the Shetland Islands. Since the incident, the Company has been working closely with its customer and local authorities in response and has pursued efforts to recover the equipment and replace missing or damaged equipment. The Company has successfully retrieved the LMRP to the rig and removed the blowout preventor from the secure well and raised the BOP to the rig. The rig has departed the location of the incident and is currently in transit to a repair facility, where the Company plans to repair the LMRP and complete related work. Consistent with previous reports, there continues to be no reports of damage to seabed infrastructure and no known environmental impacts or lower hull damage to the rig from the incident. It remains too early for the Company to reliably predict the future financial impact of the incident. Based on the facts known to the Company to date, including the impact of weather delays on the recovery process, the Company currently estimates that recovery and repair activities will result in the Ocean GreatWhite being off rate for approximately 120 to 130 days from the date of the incident and currently estimates that the rig will return to earning rate under its current contract by late May or early June 2024. The Company maintains insurance coverage for property damage with a $10 million deductible, and the Company continues to anticipate that the incident will be covered by the policy. In addition, the Company maintains loss of hire insurance on the Ocean GreatWhite. Under the loss of hire insurance policy, after a 60-day waiting period, the policy provides for the Company to receive $150,000 per day for up to 180 days for each day of lost revenue as a result of a covered property claim. If the Ocean GreatWhite is off rate for approximately 120 to 130 days, the Company estimates that the downtime would result in an aggregate of approximately $32 million to $35 million in reduced revenue during the first and second fiscal quarters of 2024 and that the Company's loss of hire insurance may provide the Company with proceeds of approximately $9 million to $10.5 million. The Company's current estimate of incremental recovery costs and repairs and maintenance is approximately $25 million to $30 million and current estimate of replacement capital expenditures is approximately $12 million to $15 million. After taking all of the relevant factors currently known to the Company into account, including the insurance deductible of $10 million, the Company currently anticipates the total estimated negative financial impact to the Company of the Ocean GreatWhite incident to be approximately $33 million to $35 million in the first half of 2024, although at this time the Company is unable to reliably predict the future financial impact of the incident and can provide no assurance that its assumptions and estimates will ultimately be realized."
OPTN

Hot Stocks

16:20 EDT OptiNose trading resumes
FF

Hot Stocks

16:04 EDT FutureFuel provides update on $2.50 per share special cash dividend - FutureFuel issued the following update with respect to its $2.50 per share special cash dividend approved by FutureFuel's Board of Directors and previously announced on March 14. The rules of the New York Stock Exchange require that special dividends representing 25% or more of the stock price of a listed security, such as the Special Dividend, be subject to an ex-dividend date of one business day after the payment date. Accordingly, as the payment date for the Special Dividend is April 9, 2024, the NYSE has set the ex-dividend date for the Special Dividend to be April 10, 2024. In addition, FutureFuel understands that trades of FutureFuel's common stock entered into during the period beginning March 25, 2024 and through April 9, 2024 will have a due bill attached for the Special Dividend. Due bills obligate sellers of FutureFuel common stock to deliver the Special Dividend to the buyer. This means that persons who purchase FutureFuel common stock during the due bill period (even if the trade will settle after the due bill period) are entitled to receive the Special Dividend, and persons who sell the stock during the due bill period are not entitled to the Special Dividend. Accordingly, if an investor wishes to receive the Special Dividend, the investor will need to hold the securities through and including the payment date of April 9, 2024. The due bill obligations are settled customarily between the brokers representing the buyers and sellers of the stock. Buyers and sellers of FutureFuel common stock should consult with their broker before trading to ensure they understand the effect of NYSE's due bill procedures. FutureFuel has no obligations for either the amount of the due bill or the processing of the due bill.
OCCI

Hot Stocks

16:02 EDT OFS Credit estimates NAV per share of $7.48-$7.58 as of February 29, 2024 - OFS Credit Company announced the following net asset value estimate as of February 29, 2024. Management's unaudited estimate of the range of our NAV per share of our common stock as of February 29, 2024 is between $7.48 and $7.58. This estimate is not a comprehensive statement of our financial condition or results for the month ended February 29, 2024. This estimate did not undergo the Company's typical quarter-end financial closing procedures.
OPTN

Hot Stocks

15:45 EDT Optinose to resume trading at 4:20 pm ET - Optinose is scheduled to resume trading at 4:20 pm ET, with quotation set to resume at 4:15 pm, according to Nasdaq. Shares were halted ahead of the company announcing that the U.S. Food and Drug Administration has approved XHANCE nasal spray for the treatment of chronic rhinosinusitis without nasal polyps in patients 18 years of age and older.
OPTN

Hot Stocks

15:36 EDT Optinose says XHANCE nasal spray receives FDA approval - Optinose announced the U.S. Food and Drug Administration has approved XHANCE nasal spray for the treatment of chronic rhinosinusitis without nasal polyps in patients 18 years of age and older. Chronic sinusitis is one of the most common chronic diseases, affecting approximately 30 million adults in the United States. Research shows that the disease impairs quality of life to a similar degree as other serious chronic conditions, such as chronic obstructive pulmonary disease, sciatica, or migraine. Chronic sinusitis is also one of the most common diagnoses in adult outpatient medicine. Chronic sinusitis is diagnosed in approximately 10 million outpatient visits, of which approximately 70% result in antibiotic prescriptions, and leads to more than 600,000 surgeries annually. Although there are FDA-approved medications to treat nasal polyps, including XHANCE, no medication had ever been approved for the more than two-thirds of chronic sinusitis patients who do not have nasal polyps - until today. "The FDA approval of XHANCE for the treatment of CRS without nasal polyps is an important milestone," said Rick Chandra, M.D., Professor of Otolaryngology-Head and Neck Surgery, Endowed Director, Roland "Ron" Eavey, MD, SM Endowed Directorship in Leadership and Education, Service Chief, Rhinology and Skull Base Surgery, Vanderbilt University. "Until today, we have been forced to use unproven therapies to try and alleviate the symptoms that these patients suffer. While we often resort to using nasal steroid sprays in this patient population, they have never been shown to be effective in large placebo-controlled clinical studies. XHANCE, which uses the Exhalation Delivery System to enable delivery of an established topical steroid to the areas of the nasal cavity and sinuses we know to be extensively inflamed, is now proven to be effective in treating our CRS patients both with and without nasal polyps."
OPTN

Hot Stocks

15:26 EDT OptiNose trading halted, news pending
LEGN JNJ

Hot Stocks

15:18 EDT Legend Biotech notes ODAC recommends Carvykti for earlier treatment of myeloma - Legend Biotech (LEGN) announced that the U.S. Food and Drug Administration Oncologic Drugs Advisory Committee, or ODAC, recommended Carvykti for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy including a proteasome inhibitor and an immunomodulatory agent and are refractory to lenalidomide. The positive recommendation follows the committee's evaluation of efficacy and safety data from the Phase 3 CARTITUDE-4 study. The committee voted unanimously in favor of Carvykti, 11 to 0, finding the risk-benefit assessment of cilta-cel for the proposed indication as favorable. A supplemental Biologics License Application, or sBLA, supported by the CARTITUDE-4 study is currently under review by the FDA with a target Prescription Drug User Fee Act, or PDUFA, date of April 5, Legend noted. "The advisory committee's positive recommendation for Carvykti brings us one step closer to helping more patients fighting relapsed and refractory multiple myeloma. We are committed to improving the lives of patients with multiple myeloma, and we're excited by the prospect of bringing our innovative therapy to patients earlier in the course of their disease," said Ying Huang, Ph.D., Chief Executive Officer of Legend Biotech. In December 2017, Legend Biotech entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, a Johnson & Johnson (JNJ) company, to develop and commercialize cilta-cel.
JNJ

Hot Stocks

15:03 EDT J&J says ODAC recommends Carvykti for earlier treatment of myeloma - Johnson & Johnson announced that the U.S. Food and Drug Administration Oncologic Drugs Advisory Committee, or ODAC, recommends Carvykti for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy including a proteasome inhibitor and an immunomodulatory agent and who are refractory to lenalidomide. The committee reviewed survival and safety data from the Phase 3 CARTITUDE-4 study and voted unanimously in favor of Carvykti, 11 to 0, finding the risk-benefit assessment of Carvykti for the proposed indication as favorable. A supplemental Biologics License Application, or sBLA, supported by the CARTITUDE-4 study is currently under review by the FDA with a Prescription Drug User Fee Act, or PDUFA, date of April 5, J&J noted. "We are pleased with the advisory committee's support for Carvykti in earlier lines of treatment based on the CARTITUDE-4 data. As a physician and researcher committed to advancing patient care, the potential of Carvykti in earlier lines of therapy represents an important therapeutic option for patients with multiple myeloma," said Jordan Schecter, M.D., Vice President, Disease Area Leader, Multiple Myeloma, Johnson & Johnson Innovative Medicine.
MSTR

Hot Stocks

15:00 EDT MicroStrategy hits 52-week high, shares up 7% to $1,798.83
JRVR GBLI

Hot Stocks

14:49 EDT James River Group jumps after Insurance Insider report of takeover approach - Global Indemnity (GBLI) has made an indicative offer of $15 per share for James River Group (JRVR) in an all-stock proposal that would value the firm at about $550M, according to Insurance Insider's Adam McNestrie. The indicative bid values the business at more than twice the current share price, the report noted. Following the report, shares of James River have jumped $1.58, or 23%, to $8.33 in Friday afternoon trading. Reference Link
JRVR

Hot Stocks

14:45 EDT James River Group jumps after Insurance Insider report of takeover approach - Global Indemnity has made an indicative offer of $15 per share for James River Group in an all-stock proposal that would value the firm at about $550M, according to Insurance Insider's Adam McNestrie. The indicative bid values the business at more than twice the current share price, the report noted. Following the report, shares of James River have jumped $1.58, or 23%, to $8.33 in Friday afternoon trading. Reference Link
CSGP...

Hot Stocks

13:13 EDT National Association of Realtors confirms $418M commission settlement - The National Association of Realtors confirmed an agreement that would end litigation of claims brought on behalf of home sellers related to broker commissions. The agreement would resolve claims against NAR, over 1M NAR members, all state/territorial and local Realtor associations, all association-owned Multiple Listing Services, and all brokerages with an NAR member as principal that had a residential transaction volume in 2022 of $2B or below, the agency said in a statement. Under the terms of the agreement, NAR would pay $418M over approximately four years. NAR has also agreed to put in place a new MLS rule prohibiting offers of broker compensation on the MLS. This would mean that offers of broker compensation could not be communicated via the MLS. "Two critical achievements of this resolution are the release of most NAR members and many industry stakeholders from liability in these matters and the fact that cooperative compensation remains a choice for consumers when buying or selling a home. NAR also secured in the agreement a mechanism for nearly all brokerage entities that had a residential transaction volume in 2022 that exceeded $2 billion and MLSs not wholly owned by Realtor associations to obtain releases efficiently if they choose to use it," the agency added. . Companies in the home realtor space include Redfin (RDFN), Zillow (Z, ZG), Opendoor Technologies (OPEN), Re/Max Holdings (RMAX), Compass (COMP) and CoStar Group (CSGP). Reference Link
BKR

Hot Stocks

13:02 EDT Baker Hughes reports U.S. rig count up 7 to 629 rigs - Baker Hughes reports that the U.S. rig count is up 7 from last week to 629 with oil rigs up 6 to 510, gas rigs up 1 to 116 and miscellaneous rigs unchanged at 3. The U.S. Rig Count is down 125 rigs from last year's count of 754 with oil rigs down 79, gas rigs down 46 and miscellaneous unchanged. The U.S. Offshore Rig Count is up 3 to 24, up 7 year-over-year. The Canada Rig Count is down 18 from last week to 207, with oil rigs down 13 to 128, and gas rigs down 5 to 79. The Canada Rig Count is unchanged from last year's count of 207, with oil rigs up 6, and gas rigs down 6.
BKR

Hot Stocks

13:00 EDT Baker Hughes reports U.S. rig count up 7 to 629 rigs
TSVT

Hot Stocks

13:00 EDT 2seventy bio trading halted, news pending
FMCC

Hot Stocks

12:29 EDT Freddie Mac names Michael Hutchins as interim CEO - Freddie Mac announced that the company has appointed President Michael T. Hutchins to the additional role of Interim CEO as the company continues its search for a permanent CEO. He also will become a member of Freddie Mac's Board of Directors. Hutchins was named President of Freddie Mac in 2020 and is a member of the company's Senior Operating Committee. He will continue serving as President and will take on the role of Interim CEO and Board member effective March 16, following the previously announced departure of CEO Michael J. DeVito, who will step down on March 15. "Mike Hutchins is a proven leader who brings a deep understanding of every aspect of Freddie Mac to the role of Interim CEO," said Lance Drummond, non-executive Chair of Freddie Mac's Board of Directors. "In addition to his knowledge of Freddie Mac, Mike's decades of experience in housing and financial services is invaluable as the company navigates a challenging market to Make Home Possible for borrowers and renters across the nation."
DESP

Hot Stocks

12:00 EDT Despegar.com rises 10.6% - Despegar.com is up 10.6%, or $1.05 to $10.94.
TG

Hot Stocks

12:00 EDT Tredegar rises 20.2% - Tredegar is up 20.2%, or 81c to $4.82.
AVD

Hot Stocks

12:00 EDT American Vanguard rises 21.0% - American Vanguard is up 21.0%, or $2.22 to $12.81.
HOUS

Hot Stocks

12:00 EDT Anywhere Real Estate falls -11.2% - Anywhere Real Estate is down -11.2%, or -66c to $5.25.
JBL

Hot Stocks

12:00 EDT Jabil falls -17.1% - Jabil is down -17.1%, or -$25.20 to $122.26.
AMPS

Hot Stocks

12:00 EDT Altus Power falls -26.2% - Altus Power is down -26.2%, or -$1.55 to $4.38.
RBGLY

Hot Stocks

11:48 EDT Reckitt stands by safety of formula, 'strongly disagrees' with jury decision - Reckitt Benckiser issued the following statement in response to a verdict received in Illinois state court on March 13 in one case concerning Necrotising enterocolotis, or NEC: "Reckitt/Mead Johnson stands by the safety of our products. We strongly reject any assertion that any of our products cause NEC, a serious gastrointestinal problem that mostly affects premature infants. While we continue to offer our deepest condolences to Ms. Watson, we strongly disagree with the jury's decision to fault Mead Johnson and award damages. We continue to believe that the allegations from the plaintiff's lawyers in this case were not supported by the science or experts in the medical community. This was underscored during the trial by a dozen neonatologists. It is important to note that this is a single verdict in a single case and should not be extrapolated. This case, and others like it, exclusively involve products used under the strict supervision of neonatologists in neonatal intensive care units and provide lifesaving nutrition options for vulnerable premature infants. We are of course, surprised and deeply disappointed with the verdict and will pursue all options to have it overturned." Reference Link
RBGLY

Hot Stocks

11:19 EDT Reckitt Benckiser plunges after jury awards $60M damages in formula verdict - Shares of Reckitt Benckiser trading in New York have fallen nearly 20% after a jury in state court in St. Clair County, Illinois awarded a woman $60M in damages after ruling that the Reckitt's Mead Johnson Nutrition unit failed to warn about the risks of necrotizing enterocolitis, or NEC, in its cow-milk-based Enfamil formula, which led to the death of the woman's premature baby. The verdict came in the first case of its kind to go to trial in the U.S. noted Bloomberg. "The jury's finding confirms what Mead Johnson folks already knew - that its formula dramatically increases the NEC risk. This is the first verdict in the US, but won't be the last, unless baby formula makers accept responsibility for their misdeeds," Ashley Keller, an attorney for the baby's mother, Jasmine Watson, said Friday. Reference Link
FOX...

Hot Stocks

10:45 EDT Former Apple executive Pete Distad named CEO of new sports streaming service - Pete Distad, who previously worked at Apple (AAPL) and was responsible for the business, operations and global distribution for Video, Sports and Apple TV+, has been named CEO of the new sports streaming service, a joint venture formed by Disney's (DIS) ESPN, Fox (FOXA) and Warner Bros. Discovery (WBD), Fox announced. Distad, who most recently served as an executive at Apple for a decade following six years at Hulu, will assume oversight of all aspects of the joint venture, including overall strategy, distribution, marketing, sales and more, Fox stated. Reference Link
HLT

Hot Stocks

10:33 EDT Hilton to acquire Graduate Hotels brand for $210M - Hilton yesterday announced an agreement with Adventurous Journeys Capital Partners to acquire the Graduate Hotels brand, which it sees as "adding a significant growth opportunity for the global hospitality leader in the fast-growing lifestyle hotel market." Hilton will pay $210M to acquire all rights to the Graduate brand worldwide, enter into franchise agreements for all existing and signed pipeline Graduate Hotels, and become responsible for the brand's future development and growth. AJ Capital will remain the owner of the more than 35 operating and pipeline Graduate properties, each of which will be operated under long-term Hilton franchise agreements. The transaction, which is expected to close in the second quarter, subject to customary closing conditions including review and approval pursuant to Hart-Scott-Rodino, will be immediately accretive to Hilton. The company expects the fee contribution for the first full year of ownership to be approximately $16M, the company stated. "Adding Graduate Hotels to our portfolio of award-winning brands accelerates our expansion in the lifestyle space by pairing an existing much-loved brand with the power of Hilton's strong commercial engine to drive growth. We have long had a high bar for adding brands to our portfolio, whether organically or through acquisition, and Graduate will be another driver of growth for us, presenting a unique opportunity to serve more guests in more sought-after destinations. With thousands of colleges and universities around the world, we believe the addressable market for the Graduate brand is 400-500 hotels globally," added Chris Nassetta, president and CEO, Hilton.
MMC

Hot Stocks

10:31 EDT Marsh McLennan's Mercer completes acquisition of Vanguard's U.S. OCIO business - Mercer announced the completion of its acquisition of Vanguard's Outsourced Chief Investment Officer business that provides investment management services for not-for-profit organizations and other institutional investors in the United States. The acquisition, announced in December of last year, expands Mercer's capabilities and expertise across investment solutions in the US. Incoming clients can elect to keep the same investment approach and team they enjoyed at Vanguard. They can now also choose to broaden their investment strategy through access to Mercer's extensive global resources, including its deep bench of investment talent, world-class thought leadership and solutions from third-party investment managers across a spectrum of asset classes, from public equities and fixed income to alternative investments like infrastructure and private credit. Approximately 120 Vanguard colleagues join Mercer today. They will be based in Mercer's offices in King of Prussia, PA, and Phoenix, AZ.
RDFN COMP

Hot Stocks

10:22 EDT Redfin, Compass fall after report says realtor group agreed to cut commissions
AGE

Hot Stocks

10:22 EDT AgeX Therapeutics Inc trading resumes
LXEH

Hot Stocks

10:21 EDT Lixiang Education Holding Co Ltd - ADR trading resumes
ZG Z

Hot Stocks

10:21 EDT Zillow falls 7% after NY Times says realtor group agreed to cut commissions
LXEH

Hot Stocks

10:16 EDT Lixiang Education Holding Co Ltd - ADR trading halted, volatility trading pause
AGE

Hot Stocks

10:12 EDT AgeX Therapeutics Inc trading halted, volatility trading pause
OTLK

Hot Stocks

10:11 EDT Outlook Therapeutics Inc trading resumes
OTLK

Hot Stocks

10:06 EDT Outlook Therapeutics Inc trading halted, volatility trading pause
JD DSITF

Hot Stocks

10:05 EDT JD.com says does not intend to make offer for Currys - In a statement issued to the London Stock Exchange, JD.com said: "Further to the announcement on 19 February 2024 that JD.com was in the very preliminary stages of evaluating a possible transaction that may include a cash offer for the entire issued share capital of Currys, JD.com today confirms that, following careful consideration, it does not intend to make an offer for Currys. This is a statement to which Rule 2.8 of the Code applies."
ODV

Hot Stocks

10:05 EDT Osisko Development Corp trading resumes
LAW

Hot Stocks

10:00 EDT CS Disco rises 11.8% - CS Disco is up 11.8%, or 81c to $7.70.
DESP

Hot Stocks

10:00 EDT Despegar.com rises 14.3% - Despegar.com is up 14.3%, or $1.41 to $11.30.
AVD

Hot Stocks

10:00 EDT American Vanguard rises 30.7% - American Vanguard is up 30.7%, or $3.25 to $13.84.
SHCO

Hot Stocks

10:00 EDT Soho House falls -10.4% - Soho House is down -10.4%, or -60c to $5.15.
JBL

Hot Stocks

10:00 EDT Jabil falls -11.1% - Jabil is down -11.1%, or -$16.32 to $131.14.
AMPS

Hot Stocks

10:00 EDT Altus Power falls -15.6% - Altus Power is down -15.6%, or -93c to $5.01.
ALTG

Hot Stocks

09:47 EDT Alta Equipment Group rises 7.1% - Alta Equipment Group is up 7.1%, or 75c to $11.26.
LAW

Hot Stocks

09:47 EDT CS Disco rises 8.7% - CS Disco is up 8.7%, or 60c to $7.49.
AVD

Hot Stocks

09:47 EDT American Vanguard rises 22.8% - American Vanguard is up 22.8%, or $2.41 to $13.00.
SMAR

Hot Stocks

09:47 EDT Smartsheet falls -11.1% - Smartsheet is down -11.1%, or -$4.48 to $35.82.
JBL

Hot Stocks

09:47 EDT Jabil falls -13.4% - Jabil is down -13.4%, or -$19.70 to $127.75.
AMPS

Hot Stocks

09:47 EDT Altus Power falls -15.7% - Altus Power is down -15.7%, or -93c to $5.01.
HCMA

Hot Stocks

09:44 EDT HCM Acquisition Corp trading resumes
FEIM

Hot Stocks

09:40 EDT Frequency Electronics trading resumes
ODV

Hot Stocks

09:36 EDT Osisko Development announces mineral resource update for Trixie Deposit - Osisko Development announces an updated mineral resource estimate for its 100%-owned underground Trixie deposit, within the Company's wider Tintic Project, located in the historic East Tintic Mining District in central Utah, U.S.A. The 2024 Trixie MRE incorporated an additional 1,674 underground chip samples over 1,678 meters of underground development, and 7,385 m of drilling in 122 holes completed by the Company since the release of the initial Trixie MRE, with an effective date of January 10, 2023. Highlights: Measured resources of 119,847 tonnes grading 27.36 grams per tonne gold and 61.73 g/t silver, for a total of 105,437 ounces Au and 237,868 oz Ag. Indicated resources of 124,743 tonnes grading 11.17 g/t Au and 59.89 g/t Ag, for a total of 44,811 oz Au and 240,211 oz Ag. Inferred resources of 201,603 tonnes grading 7.80 g/t Au and 48.55 g/t Ag, for a total of 50,569 oz Au and 314,678 oz Ag. Relative to the 2023 Trixie MRE, contained gold ounces in measured and indicated resources decreased by 29% and inferred resources decreased by 79% primarily due to lower estimated grades that incorporated an updated geologic model interpretation and conversion of inferred resources. Drill results and underground mapping from the 2023 exploration program improved the knowledge of the extent and distribution of mineralization, resulting in modeling improvements to both mineralization and the historical mine shape model. Chris Lodder, President, stated, "The 2024 Trixie MRE incorporates changes to our interpretation of the main mineralized structures and reflects better understanding of the structural controls of the deposit and realistic mining parameters following our exploration and test mining work in 2023. To date exploration and mining occurred on less than 10% of known mineralized structures in the west Tintic district and thus, we see significant precious metal potential at depth, on parallel structures to Trixie, along the Trixie and Sioux Ajax faults to the north and south, as well as around all historic high-grade gold mines in the West Tintic District. These high-grade gold targets, combined with the copper-gold porphyry potential where drilling is underway, and a large area of polymetallic carbonate replacement potential, illustrate that we have only scratched the surface in understanding the overall metal endowment potential of the Tintic district."
FSR

Hot Stocks

09:35 EDT Fisker jumps after saying focused on raising capital, finding partner - Fisker said in a statement last night: "As a matter of company policy, Fisker does not comment on market rumors and speculation. However, Fisker often works with outside advisors to help manage its business and assist in developing and executing strategies. Fisker is focused on raising additional capital and engaging in a strategic partnership with a large automaker. The company is also continuing to pursue its shift to a Dealer Partnership model in both North America and Europe. The leadership team is laser-focused on these efforts." Shares of Fisker are up 28% to 20c in early trading. The stock traded this week after the Wall Street Journal reported that Fisker has hired restructuring advisors FTI Consulting and the law firm Davis Polk to help with a potential bankruptcy filing for the company.
CNEY

Hot Stocks

09:31 EDT CN Energy unit receives re-order from water purification customer - CN Energy Group announced that its wholly owned subsidiary, Zhejiang CN Energy New Materials Co., Ltd., has received a re-order to supply its high-quality wood-based activated carbon to an existing customer for application in the water purification industry.
FEIM

Hot Stocks

09:30 EDT Frequency Electronics trading halted, volatility trading pause
HCMA

Hot Stocks

09:30 EDT HCM Acquisition Corp trading halted, volatility trading pause
ODV

Hot Stocks

09:25 EDT Osisko Development Corp trading halted, news pending
FEIM

Hot Stocks

09:16 EDT Frequency Electronics issues clarification to earnings call - On yesterday's earnings call, the Company discussed program charges that adversely affected its gross margins for the quarter ended January 31, 2024. As a result of percentage of completion accounting, these charges included a temporary reversal of revenue. The Company expects to recover approximately $1.2 million of this revenue during this calendar year. Because the costs have been conservatively estimated and already charged, when this revenue is realized, the Company estimates that it will be at normal or higher than average corporate gross margins.
FCUV

Hot Stocks

09:13 EDT Focus Universal engages PX SPAC Capital - Focus Universal has engaged PX SPAC Capital Inc, to raise its visibility and strengthen its relationships within the investment community.
SHIP

Hot Stocks

09:12 EDT Seanergy Marine declares special cash dividend of 7.5c per share - Continuing its quarterly dividend payments, the Company has declared a regular cash dividend of $0.025 per common share for the fourth quarter of 2023 payable on or about April 10, 2024 to all shareholders of record as of March 25, 2024. In addition, the Company has declared a special dividend of $0.075 per common share to all shareholders of record as of March 25, 2024 which will be paid on or about April 10, 2024.
LINC

Hot Stocks

09:06 EDT Lincoln Educational chair Barry Morrow retires, John Bartholdson to succeed - Lincoln Educational Services announced that J. Barry Morrow has notified the Company's Board of Directors of his decision not to stand for re-election at the Company's 2024 Annual Meeting of Shareholders. Mr. Morrow joined the Board in 2006 and currently serves as non-executive Chair of the Board. The Company also announced that the Board of Directors had selected current Board member John Bartholdson to succeed Mr. Morrow as the next Chair of the Board following the 2024 Annual Meeting of Shareholders to be held in May. Mr. Bartholdson has been a member of the Board of Directors since 2019.
MTH

Hot Stocks

09:05 EDT Meritage Homes director Raymond Oppel to retire - Meritage Homes announced that board director Raymond Oppel will not seek re-election to the Board at the Company's upcoming annual meeting of shareholders and will retire from his position effective May 16, 2024. Mr. Oppel joined Meritage's Board in 1997 and during his tenure, chaired the Executive Compensation Committee. He is currently a member of the Executive Compensation and Land Committees.
SCLX VRPX

Hot Stocks

09:05 EDT Scilex enters release, settlement agreement with Virpax Pharmaceuticals - Scilex Holding Company (SCLX) announced that the U.S. Bankruptcy Court for the Southern District of Texas, in connection with the bankruptcy proceedings of Sorrento Therapeutics, Scilex's former controlling stockholder, approved the settlement and mutual release agreement between Scilex's wholly owned subsidiary, Scilex Pharmaceuticals, and Sorrento, on the one hand, and Virpax Pharmaceuticals (VRPX), on the other hand. The Definitive Settlement Agreement relates to the term sheet previously announced by Scilex on February 26, 2024, regarding a mutual release and settlement agreement between Scilex Pharma, Sorrento and Virpax in respect of the action filed by Scilex Pharma and Sorrento against Anthony Mack, former President of Scilex Pharma and Virpax, a company founded and then headed by Mr. Mack. Pursuant to the Definitive Settlement Agreement, Virpax is obligated to make the following payments to the Company: $3.5 million by March 18, 2024; $2.5 million by July 1, 2024; and to the extent any of the following drug candidates are ever sold, royalty payments of 6% of annual Net Sales of Epoladerm; 6% of annual Net Sales of Probudur; and 6% of annual Net Sales of Envelta. Such royalty payments will end upon the later of expiration of the last-to-expire valid patent claim of Virpax or its licensor covering the manufacture, use or sale of such product in such country; and expiration of any period of regulatory exclusivity for such product in such country. Pursuant to the Definitive Settlement Agreement, each of the Plaintiffs and Virpax provide mutual releases of all claims that exist as of March 14, 2024, whether known or unknown, arising from any allegations set forth in the Action. The Plaintiffs' release relates to claims against Virpax only, which does not affect their claims against Mr. Mack. Plaintiffs have not released Mr. Mack, and litigation against him remains ongoing. Plaintiffs' release as to Virpax is conditioned upon Virpax's Initial Payment.
GLMD

Hot Stocks

09:01 EDT Galmed announces grant of European patent - Galmed Pharmaceuticals announced the grant of a European patent related to the use of a combination of Aramchol and Resmetirom for the treatment of NASH/MASH and liver fibrosis. The patent was granted in France, Germany, Italy, the Netherlands and the United Kingdom and the approval of the patent in the United States and other countries is pending. With this latest patent, Galmed is strengthening and extending the patent protection of its lead compound, Aramchol, until September 2039.
GRPN

Hot Stocks

08:42 EDT Groupon expects 1H24 revenue to decline y/y; 2H24 revenue to increase y/y
VEEE

Hot Stocks

08:35 EDT Twin Vee PowerCats expands dealership network with Maz Boats - Twin Vee PowerCats announced a significant expansion of its authorized dealer network with the addition of Maz Boats as its exclusive dealer for Dubai, United Arab Emirates and other Gulf Cooperation Council countries like Kuwait, Saudi Arabia, Oman, and Qatar. This new partnership marks the first time in its nearly thirty-year history that Twin Vee products will be sold in the Middle East and underscores the Company's dedication to growing its market share internationally and tapping into the demand for high-quality marine vessels in the region.
MARA APLD

Hot Stocks

08:34 EDT Marathon Digital to acquire bitcoin mining data center for $87.3M - Marathon Digital Holdings (MARA) has entered into a definitive purchase agreement to acquire Applied Digital Corporation's (APLD) Bitcoin mining data center in Garden City, Texas, with a name plate capacity of 200 megawatts, for a purchase price of $87.3M, or approximately $437,000 per megawatt, prior to any purchase price adjustments. Marathon will pay the purchase price in cash from its balance sheet. This transaction is Marathon's second major acquisition of data centers dedicated to Bitcoin mining in the last four months and increases the amount of self-owned and operated megawatts in Marathon's Bitcoin mining portfolio to 54%. Prior to the acquisition of its first two data centers, which closed in January of this year, Marathon's Bitcoin mining portfolio consisted of 584 megawatts, 3% of which resided on sites directly owned and operated by the Company. Following the close of this acquisition and the anticipated expansion of the site in 2024, Marathon will have increased the number of megawatts in its mining portfolio to 1.1 gigawatts, 54% of which will reside on sites directly owned and operated by the Company. The Bitcoin mining data center in Garden City, Texas is located adjacent to a wind farm and uses predominantly renewable energy. It was constructed and energized in 2023 and supports a workforce of approximately 25 employees. At this site, Marathon is currently converting approximately 100 megawatts into economic value via Bitcoin mining. By acquiring this data center, Marathon will take direct ownership of its current on-site operations and will also gain an additional 100 megawatts of capacity in which to expand, 32 megawatts of which are expected to be available as of the closing date and the remainder of which are subject to regulatory approvals. Marathon expects to expand its presence at the site in 2024 by an additional 100 megawatts to accommodate a total of 200-megawatts of capacity dedicated exclusively to Marathon's Bitcoin mining operations. In addition to providing Marathon with more influential and secure ownership of its operations as well as expansion opportunities, this transaction is also expected to reduce the cost per coin of Marathon's current operations at the site by approximately 20%. The transaction is subject to customary closing conditions and is expected to close in the second quarter of 2024.
GRPN

Hot Stocks

08:33 EDT Groupon says ~$100M in potential future non-core asset sales - Including: Remaining stake in SumUp; GiftCloud; Intellectual property. Says, "A combination of improved financial performance and increased liquidity resolves our going concern issue."
LMFA

Hot Stocks

08:32 EDT LM Funding to take early delivery of 300 S21 Bitmain mining machines - LM Funding America will take early delivery of the previously announced purchase of 300 Bitmain S21 Antminer machines. The S21 is a high efficiency, high hash rate machine mining SHA-256 algorithm manufactured by Bitmain that generates a hash rate of 200 TH/s with a power consumption of 3,500 W.
AISP

Hot Stocks

08:32 EDT Airship AI announces tender award with government agency in Singapore - Airship AI Holdings has been awarded a six-figure multi-year software and services contract by an agency within the Singapore Government for the Company's Acropolis Enterprise Sensor Management video and data management platform supporting emerging public safety requirements.
VERB META

Hot Stocks

08:31 EDT VERB's MARKET.live launches Facebook, Instagram shopping tech integration - Verb Technology Company announces its latest technological integration achievement with META, creating a seamless, native, friction-free checkout process for Facebook and Instagram users to purchase MARKET.live vendors' products within each of those popular apps. In short, this integration allows Facebook and Instagram users to browse products featured in MARKET.live shoppable videos, place products in a native shopping cart and checkout - all without leaving Facebook or Instagram. This integration marks a significant enhancement, allowing MARKET.live to showcase vendor products not only on its own MARKET.live platform but also through shoppable content on Facebook and Instagram, creating a massive expansion of the addressable audience of prospective buyers who want to shop without leaving their Facebook or Instagram app.
ATXI

Hot Stocks

08:23 EDT Avenue Therapeutics granted extension for Nasdaq compliance - Avenue Therapeutics announced that by decision dated March 11, 2024, the Nasdaq Hearings Panel granted the Company's request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price and $2.5 million stockholders' equity requirements, through May 20, 2024. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.
GRPN

Hot Stocks

08:22 EDT Groupon says 'moving to building phase' of transformation plan - Expects timeline for building for growth ~18-36 months. Expects to show improvements in financial performance during transformation. Says has "solid financial foundation." Sees "massive opportunity" to leverage AI across the business. Says last-minute gifting is a "growth opportunity" for the company. Says will continue to reduce promotional spending. Says, "Groupon is a 15 year old company, but we see ourselves at Day Zero." Comments taken from Q4 earnings conference call.
CLNN

Hot Stocks

08:20 EDT Clene announces peer-reviewed publication on CNM-Au8 - Clene reported the publication of "Protein Corona Composition of Gold Nanocatalysts" in the journal ACS Pharmacology & Translational Science, a journal of the American Chemical Society that publishes innovative and impactful research with translational relevance across a broad spectrum of biological sciences. The publication, led by Morteza Mahmoudi, associate professor in the Precision Health program and Department of Radiology at the Michigan State University College of Human Medicine, and members of his laboratory, fully characterized the proteins from human blood plasma that form the protein corona of the gold nanocrystals of CNM-Au8, an investigational drug in development for the treatment of neurodegenerative diseases. CNM-Au8 is comprised of a suspension of clean-surfaced, faceted gold nanocrystals that, once swallowed, pass through the gastrointestinal tract, and enter the body's circulatory system, where they interact with, and become coated by, blood proteins and other biomolecules, forming the 'protein/biomolecular corona.' Using multiple state-of-the-art techniques that have been refined and optimized by the Mahmoudi lab, the group characterized the CNM-Au8 nanocrystals' protein corona and made several important observations: Protein corona-coated CNM-Au8 nanocrystals are less likely to aggregate than the non-coated nanocrystals. The specific apolipoproteins that are enriched on the surfaces of CNM-Au8 nanocrystals are known to bind to specific receptors on the blood-brain barrier and promote the transport of substances across the BBB. The protein corona did not show a significant increase in complement proteins and fibrinogens compared to these proteins' relative amounts in human plasma; coupled with the enrichment of apolipoproteins in these coronas, this corona composition is likely to increase colloidal stability and decrease inflammatory reactions from immune cells, consequently extending their circulation time in the blood. A Phase 3 registrational clinical trial of CNM-Au8 for the treatment of the progressive neurodegenerative disease, amyotrophic lateral sclerosis, is presently planned to launch in 2024.
JSPR

Hot Stocks

08:19 EDT Jasper Therapeutics presents Phase 1b/2a data on briquilimab - Jasper Therapeutics announced additional Phase 1b/2a data on briquilimab as a conditioning agent in the treatment of Fanconi Anemia. The data was presented at the 2024 Stanford Medicine Center for Definitive and Curative Medicine Symposium on March 13, 2024, in Palo Alto, California. The ongoing investigator initiated Phase 1b/2a clinical trial is evaluating a conditioning regimen that includes intravenous briquilimab as a potential treatment for FA patients in bone marrow failure. Data from the study show that briquilimab infusion has a promising safety profile and appears to be well tolerated in patients with FA, with all six patients treated achieving full donor engraftment and full blood count recovery.
APLD MARA

Hot Stocks

08:18 EDT Applied Digital to sell Garden City campus to Marathon Digital for $97.3M - Applied Digital Corporation (APLD) announced that it has entered into a definitive agreement to sell its 200 megawatt campus in Garden City, TX to Marathon Digital Holdings (MARA) for a net purchase price of approximately $87.3 million, with a gross purchase price of $97.3 million after adjustments contemplated in the purchase agreement. In addition to the purchase price, this transaction will release $12 million of restricted cash previously committed as collateral for the site's letter of credit. The transaction is subject to customary closing conditions and is expected to close in the second quarter of calendar 2024. Completed in 2023, Applied Digital's Garden City campus provides hosting agreements for blockchain mining clients, such as Marathon, under third-party arrangements. Applied Digital exclusively focuses on infrastructure and support services and does not currently own any equipment placed in the facility. Marathon has been a significant customer at the Garden City campus, operating under a multi-year colocation hosting agreement, and will remain a customer at our North Dakota blockchain hosting facilities.
GCT

Hot Stocks

08:16 EDT GigaCloud reports warehouse fire in Japan - On March 9, 2024, one of the Company's warehouses in Japan suffered damages due to a warehouse fire. While the Company is still evaluating the impact caused by the warehouse fire, the Company estimated approximately $1.8 million in damages with respect to the cost of its inventory held at the warehouse. The Company has insurance coverage associated with the damages to the inventory and warehouse equipment. Furthermore, the Company has a total of four warehouses in Japan and the Company has shifted our warehousing operations in Japan to the other three warehouses to minimize any disruptions to the Company's operations in Japan.
PRPH

Hot Stocks

08:13 EDT ProPhase Labs sees significant sequential improvement in revenues going forward - The company said, "The end of 2023 marked a period of significant capacity expansion and growth for Pharmaloz Manufacturing as well as a pivotal transformation for the Company, transitioning from a clinical laboratory framework to a leader in whole genome sequencing. There is a significant shortage of lozenge manufacturing capacity in both the U.S. and globally. The Company is now in late-stage negotiations with four major lozenge brands. All are short manufacturing capacity and need a reliable FDA approved manufacturer. PMI recently acquired cutting-edge automation equipment and, with other operating efficiencies, is set to escalate plant capacity by over 50% immediately, raising annual production capability from below $10 million to over $15 million. The installation of a second lozenge production line and further automation in Q2 2024 are projected to approximately triple capacity entering Q3 to a $45 million potential run-rate. Additional equipment set to arrive by Q4 2024 could increase annual production capabilities in the first half of 2025 to a range of $80-$100 million. Regarding Nebula Genomics, given the positive reception at major genomics conferences during 2023 and demand for whole genome sequencing, management determined that the opportunity for its business was so significant that it shifted significant laboratory resources to whole genome sequencing and eliminated certain legacy clinical lab initiatives, including equipment and personnel. During this transformative phase to right size and focus the laboratory operations, ProPhase faced numerous one-time charges, including more than $2.4 million in startup costs. It also equipped Nebula Genomics with four platforms of state-of-the-art technology. With this significant repositioning completed, Nebula Genomics can now deliver low-cost, high-precision genomic diagnostics across North America and the global market. Depending on market conditions, our ability to generate enhanced revenues, and other factors, the Company anticipates that there will be a significant sequential improvement in revenues and EBITDA going forward, driven by strategic advancements across its subsidiaries. Key recent developments include: Nebula Genomics has marked a milestone with the execution of an international revenue generating business-to-business agreement with MenaDNA, Inc. This agreement presents the possibility for significant expansion of its global footprint and paves the way for prospective future revenue streams. Several additional and meaningful distribution arrangements, both domestically as well as internationally, are anticipated during the next few months, if not sooner, but cannot be assured. Our Pharmaloz Manufacturing subsidiary has significantly increased its production capabilities with the addition of new automation equipment and additional equipment to be installed in the coming months. With the recent acquisition of significant new customers, recent price increases and potential additional major deals on the near-term horizon, the Company is already experiencing a dramatic increase in both revenues and profits, which the Company expects to continue as the year progresses subject to market conditions and other factors. The BE-Smart Esophageal Cancer Test and the dietary supplement Equivir are both anticipated to be in commercialization in the coming months and may provide significant contributions to both the top and bottom line in the second half of 2024."
ZFOX

Hot Stocks

08:08 EDT ZeroFox will not provide guidance for Q1, 2025 - As announced on February 6, 2024, ZeroFox has entered into a definitive agreement to be acquired by Haveli Investments in an all-cash transaction with an enterprise value of approximately $350 million. The transaction is expected to close in the first half of 2024, subject to customary closing conditions, including approval by ZeroFox stockholders and the receipt of required regulatory approvals. The transaction is not subject to any financing condition. Upon the completion of the transaction, ZeroFox's common stock and warrants will no longer be publicly listed on the Nasdaq Global Market and the Nasdaq Capital Market, respectively, and ZeroFox will become a privately held company. Given the transaction with Haveli Investments, ZeroFox will not be hosting an earnings conference call or live webcast to discuss its fourth quarter and fiscal year 2024 financial results and ZeroFox will not be providing guidance for the first quarter or full fiscal year 2025. For further detail and discussion of ZeroFox's financial performance please refer to ZeroFox's Annual Report on Form 10-K for the fiscal year ended January 31, 2024.
LTRN

Hot Stocks

08:04 EDT Lantern Pharma doses first two patients in LP-284 trial - Lantern Pharma announced the dosing of the first two patients in the Phase 1 clinical trial evaluating Lantern's investigational new drug LP-284 in patients with relapsed or refractory non-Hodgkin's lymphoma, or NHL, including mantle cell lymphoma, or MCL, and double hit lymphoma, or DHL, and other high-grade B-cell lymphomas, or HGBL, as well as other select solid tumors and sarcomas. Recently, Lantern Pharma's AI platform, RADR is expected to exceed 100 billion data points during 2024, and has been crucial in uncovering and accelerating indications for LP-284 as well as other drug-candidates that are in development.
GOLD

Hot Stocks

07:55 EDT Barrick Gold to grow production, value on global asset foundation - Barrick's peerless gold and rapidly growing copper portfolios now extend across all the major gold and copper districts worldwide, providing the company with a solid base from which to grow its production and value, directed by a proven strategy and supported by a broad spectrum of skills, says president and chief executive Mark Bristow in the 2023 Annual Report. "Discovery and development are the true drivers of value and our strong focus on exploration is evident in our widespread hunt for new discoveries with Tier One potential as well as reserve replenishment opportunities," he says. He notes that Barrick has a unique record of more than replacing depleted reserves. Last year, it increased its gold reserves to 77 million ounces and replaced 112% of its annual gold equivalent production. Since 2019, it has organically added 29 million ounces of attributable reserves which, on a 100% basis, represents 44 million ounces of reserve addition across all Barrick-managed mines. "Our proven ability to replace the ounces of gold and pounds of copper we mine, and the organic growth opportunities embedded in our business, give us the confidence to believe that we can deliver on and continue to extend our 10-year gold and copper production forecast without dilutionary acquisitions. As a result of this, we also continue to forecast an increase of more than 30% in gold equivalent production by the end of this decade." Year-on-year operating cash flow increased by 7%, free cash flow grew by 50% and adjusted net earnings rose by 12%. The performance of our business and the continued strength of our balance sheet allowed us to maintain a robust dividend for our shareholders in 2023. "Barrick's commitment to real sustainability has long been the bedrock of the business and integrates all aspects of environmental and community responsibilities. This strategy is based on sharing the benefits of our operations with all our stakeholders and is fundamental to our social licence to operate," Bristow said.
TGGI

Hot Stocks

07:50 EDT Trans Global Group, Zhongneng Aoyin to launch AI Chinese medicine platform - Trans Global Group and Zhongneng Aoyin Capital formally signed an industrial restructuring agreement. Universal Group used 1% of the company's shares for a total of 1000,000,000 shares in exchange for 3.5% of the shares of Hong Kong Aoyin Capital. A wholly-owned subsidiary of Hong Kong Zhongneng Aoyin Capital is Zhongneng Aoyin Digital Security Guard Technology Co., Ltd. The company has launched its own controllable database SAFEDB, which has the characteristics of high security, high reliability and high performance. Provide infrastructure support services to many international and domestic technology companies. As Chinese traditional medicine culture becomes more and more popular and applied around the world, TGGI and Hong Kong-based Zhongneng Aoyin Capital will jointly launch an AI traditional Chinese medicine platform in the near future to collect human health data through smart wearable devices and then upload the relevant data to AI The TCM platform conducts real-time analysis and issues TCM diagnosis and treatment suggestions, providing each user with 24-hour accompanying TCM doctors.
CYBN

Hot Stocks

07:39 EDT Cybin initiates CYB004 study - Cybin announced the initiation of a Phase 2 proof-of-concept study of CYB004, its proprietary DMT molecule in development for the treatment of GAD. In January, the FDA cleared Cybin's Investigational new drug application for CYB004.
SWI

Hot Stocks

07:37 EDT SolarWinds declares $1.00 per share special cash dividend - SolarWinds announced that its board of directors has declared a special cash dividend on the company's common stock of $1.00 per share, payable on April 15 to stockholders of record as of the close of business on April 3. The aggregate payment will be approximately $168M, which represents our approximate free cash flow for fiscal year 2023.
GRPN

Hot Stocks

07:33 EDT Groupon: No longer substantial doubt about ability to continue as going concern - The company stated, "Beginning in the fourth quarter 2022, we disclosed conditions and events, when considered in the aggregate, that raised substantial doubt about our ability to continue as a going concern. Since then, we have taken the following actions to improve our liquidity: Our operating cash flow performance has improved for the year ended December 31, 2023 compared to December 31, 2022 and for three months ended December 31, 2023 compared to December 31, 2022. In the fourth quarter 2023, we received $18.9 million in proceeds from the sale of a portion of our non-controlling equity interest in SumUp. In January 2024, we closed a fully backstopped Rights Offering that was oversubscribed and raised $80.0 million. In February 2024, we prepaid $43.1 million and terminated our credit facility in advance of its maturity in May 2024. Accordingly, management has concluded that there is no longer substantial doubt about our ability to continue as a going concern."
TSE

Hot Stocks

07:20 EDT Trinseo announces potential closure of virgin polycarbonate facility in Germany - Trinseo announced it has initiated an information and consultation process with the Works Council of Trinseo Deutschland Anlagengesellschaft regarding the potential closure of its virgin polycarbonate, or PC, production site in Stade, Germany. The company expects to seek board approval of the closure in 2024 following the Works Council consultation process. If an agreement is reached, Trinseo will no longer produce virgin PC and will obtain PC for its downstream businesses entirely via external purchases. In comparison to 2023 results, the action is expected to increase annual profitability by $15M to $20M. "Unfortunately, we continue to see demand soften, and price declines due to the oversupply caused by offshore producers pushing material into the EMEA market. We anticipate these conditions to continue in 2024 and beyond. Additionally, our fixed operating costs at Stade are significant, placing a further strain on our financial viability at this location," said CEO, Frank Bozich.
PMTS

Hot Stocks

07:17 EDT CPI Card Group announces stock repurchase from Tricor Pacific - CPI Card Group announced that it has entered into a second agreement to purchase shares of the company's common stock from Tricor Pacific Capital Partners, a fund managed by Parallel49 Equity, under the company's previously announced $20M share repurchase authorization. The new agreement covers the period April through June and follows an initial agreement that expires on March 31. Pursuant to the new agreement, the company has agreed to purchase from Parallel49, and Parallel49 has agreed to sell to the company, a number of shares equal to three times the number of shares acquired by the company in the open market from non-Parallel49 holders from time to time during the period April 1 through June 30, up to a maximum of 325,000 shares. The purchase price for the shares to be acquired from Parallel49 will be equivalent to 98% of the volume-weighted average purchase price of shares bought by the Company in the open market from non-Parallel49 holders during that time period, with settlement occurring within five days of the end of the period. The agreement has been approved by the audit committee of the board of directors of the company. The company will settle with Parallel49 for purchases made under the first agreement, which covered the period December 11, 2023 through March 31, within five days after March 31. As of December 31, 2023, Parallel49 owned 6.6 million shares of CPI common stock, or approximately 57% of outstanding shares. CPI purchasing shares from Parallel49 at a 3 to 1 ratio to open market purchases maintains or reduces the Parallel49 ownership percentage in CPI and minimizes the share repurchase program's impact on CPI's public float. CPI and Parallel49 may enter into similar agreements in the future, consistent with the company's share repurchase authorization. The company has an existing authorization to purchase up to $20M of its common stock through open market purchases and privately negotiated transactions, expiring on December 31.
SSNT

Hot Stocks

07:13 EDT SilverSun Technologies stockholders approve equity investment - Jacobs Private Equity II and SilverSun Technologies announced that SilverSun stockholders overwhelmingly voted to approve the transactions contemplated by the previously announced equity investment agreement among SilverSun, JPE and certain minority co-investors, and other related proposals. Pursuant to the Investment Agreement, JPE and the minority co-investors will invest $1 billion in cash into SilverSun. Based on a preliminary tabulation of the stockholder vote, approximately 99.5% of all votes cast, which represents approximately 65.7% of all outstanding shares on February 12, 2024, the record date for the special meeting, were voted in favor of the equity investment. The equity investment transactions are subject to customary closing conditions, and are expected to be completed in 2024.
THR

Hot Stocks

07:12 EDT Thermon Group announces $50M share repurchase program - Thermon Group announced that its Board of Directors has authorized the repurchase of up to $50 million of Thermon's outstanding shares of common stock through March 15, 2027
ACHFF

Hot Stocks

07:11 EDT Arch Biopartners announces University of Calgary joins LSALT Peptide trial - Arch Biopartners announced that a research team from the University of Calgary's Cumming School of Medicine has joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury. LSALT peptide is the Company's lead drug candidate for preventing and treating inflammation injury in the kidneys, lungs and liver. Dr. Gregory's clinical team has submitted an application to the local Research Ethics Board for permission to participate in the trial. The addition of the first Canadian clinical site increases the number of trial sites to four, with three hospitals in Turkey currently recruiting patients. There are three additional hospital sites in Turkey pending activation into the trial. The Arch Biopartners team is currently working with two other hospital sites in Canada to prepare for their participation in this Phase II trial.
BTAI

Hot Stocks

07:09 EDT BioXcel Therapeutics announces European Patent Office grant - BioXcel Therapeutics reported that the European Patent Office granted the Company's European Patent No. 3,562,486 on March 13, 2024. The 486 patent covers the use of dexmedetomidine administered sublingually to treat agitation in individuals with dementia. The patent encompasses a broad range of dosage forms, including films such as BXCL501 wafers, and tablets, at dexmedetomidine doses ranging from 3 mcg to 100 mcg.
GTI

Hot Stocks

07:08 EDT Graphjet Technology begins trading on Nasdaq Global Market - Graphjet Technology has been approved for listing on Nasdaq Global Market under the symbol "GTI." The Company begins trading at 9:30 am. "This is a huge milestone for Graphjet as we officially begin trading as a public company for the first time on the Nasdaq and establish a presence in the U.S. capital markets," said Aiden Lee, CEO of Graphjet. "Graphjet's journey as the leading supplier of graphite and graphene to the key U.S. market is just getting started and we look forward to expanding our manufacturing capacity to support our growing list of current and prospective customers. We will continue to work at the forefront of next-generation technologies as the first player to efficiently and sustainably recycle palm kernel agriculture waste and transform it into highly valuable, strategic products."
BOOM

Hot Stocks

07:07 EDT DMC Global enters cooperation agreement with Bradley Radoff - DMC Global announced that the Company has entered into a cooperation agreement with Bradley L. Radoff and his affiliate, pursuant to which the Company and the Radoff Parties will identify and mutually agree to appoint a new independent director to the board of directors of DMC with expertise and experience in the building products sector. Pursuant to the terms of Cooperation Agreement, the Board will promptly commence a formal search for qualified director candidates, in accordance with DMC's established process for director recruitment and with the aid of a nationally recognized executive search firm. Prior to entering into the Cooperation Agreement, consistent with the Board's refreshment practices and its retirement policy contained in DMC's Corporate Governance Guidelines, the Board determined that Robert Cohen and Richard Graff will not be renominated for election at the 2024 Annual Meeting. As a result, effective as of the 2024 Annual Meeting, the size of the Board will be reduced to seven directors, subject to increase for the appointment of the new independent director. The Radoff Parties have agreed to certain customary provisions, including standstill and voting obligations.
BRC

Hot Stocks

07:06 EDT Brady plans to acquire Gravotech for EUR 123M - Brady Corporation has entered into exclusive negotiations to acquire Gravotech Holding for approximately EUR 123M. Brady expects to fund the transaction with cash on hand as well as with borrowings on its existing credit agreement, and expects to close the transaction by the end of its fiscal year ending July 31, 2024, subject to prior completion of the information-consultation processes under French law and closing conditions, including regulatory clearances. Gravotech, with sales of EUR 112M in the year ending December 31, 2023, is a leader in specialized marking and engraving solutions intended for a variety of industries and applications. Gravotech was founded in 1938 and is headquartered in Lyon, France. Gravotech is a leader in the design, manufacture and distribution of innovative solutions for specialized engraving, marking and cutting, offering laser, mechanical engraving, scribing and dot peen capabilities. It manufactures machines and consumables and develops CAD software, and has an international presence in the U.S., Latin America, Europe and Asia-Pacific. Brady is a leader in high-performance industrial printers and adhesive materials, and the acquisition of Gravotech will add specialized direct part marking and engraving capabilities to Brady's extensive product identification offering. Excluding acquisition-related costs, Brady expects this acquisition to be immaterial to earnings per diluted share for the remainder of the fiscal year ending July 31, 2024.
SMLP

Hot Stocks

07:05 EDT Summit Midstream sees 170-230 well connections in 2024 - Management said, "We expect approximately 170 to 230 well connections in 2024. Of the expected well connections in 2024, approximately 15% are dry-gas oriented wells, approximately 35% are liquids-rich gas-oriented wells and approximately 50% are crude-oil oriented wells. Customers are currently running five rigs behind our systems, with more than 140 DUCs, providing line of sight to the 2024 estimated well connections and associated volume growth. We expect our wholly owned natural gas gathering system throughput to range from 1,255 MMcf/d to 1,345 MMcf/d, with volume throughput growth expected behind our Rockies and Barnett segments. OGC gross volume throughput is expected to range from 775 MMcf/d to 825 MMcf/d, as compared to 779 MMcf/d in 2023, representing approximately 2.7% year-over-year growth at the mid-point of the guidance range. Double E existing take-or-pay contracts of 985 MMcf/d will contractually increase to 1,020 MMcf/d beginning in November 2024. We expect to complete the Janus Plant connection in the first quarter 2025. Liquids volumes are expected to range from 65 Mbbl/d to 75 Mbbl/d. Adjusted EBITDA is expected to range from $260 million to $300 million, representing approximately 5% year-over-year growth at the midpoint. Our 2024 capital expenditure guidance of $30 million to $40 million, excluding Double E, includes capital reimbursements related to specific development projects with certain customers. Our full year 2024 growth capex guidance range is primarily related to new pad connections in the Rockies segment. Included in this range is approximately $10 million to $15 million of maintenance capex. Double E capital expenditures for 2024 are expected to be approximately $5 million, net to SMLP, primarily related to connecting the Janus Plant."
NHYDY

Hot Stocks

07:04 EDT Norsk Hydro: Industry, Norwegian government agree on CO2 compensation scheme - The Norwegian government, industry associations and trade unions have reached an agreement on the future of the Norwegian CO2 compensation scheme, valid from 2024 until 2030. The agreement between the Norwegian government, Norsk Industri, Industri Energi & Forbundet for ledelse og teknikk, Fellesforbundet, LO, and NHO is valid from 2024 until 2030. It includes an annual maximum CO2 compensation for eligible industries of NOK 7 billion. The CO2 quota price floor that was introduced in 2022, and further increased for 2023, will be fully removed. The compensation cap will be subject to inflation adjustment. The revised CO2 compensation scheme includes a commitment for the industries to implement emission reduction and energy efficiency measures corresponding to 40 percent of the CO2 compensation paid. The revised CO2 compensation scheme will be subject to approval by EFTA Surveillance Authority, as well as the Norwegian parliament annual approval as part of the ordinary state budget process. The CO2 compensation scheme is linked to the EU emissions trading system. The scheme partially compensates for the unintended CO2 price effect to Norwegian power price from the European ETS system. In Norway, Hydro utilizes 100 percent renewable energy that does not emit CO2 in its aluminium production. However, due to interconnection with the European power market, CO2 costs are also affecting Norwegian power prices. Based on current production, it is estimated that Hydro will be eligible for a CO2 compensation of approximately NOK 3.2 billion for 2024, payable in 2025. The purpose of the CO2 compensation scheme is to create a level playing field for European energy intensive industries and prevent carbon leakage, which means energy intensive industries move production to countries without costs for CO2 emissions, but with similar or higher CO2 emissions.
SMLP

Hot Stocks

07:02 EDT Summit Midstream CEO says strategic review 'entering advanced stages' - Heath Deneke, President, CEO, and Chairman, commented, "Summit delivered solid fourth quarter 2023 financial and operating results representing run-rate Adjusted EBITDA of $300 million. It has been a very busy quarter, advancing a range of strategic alternatives and executing several key commercial milestones. We are pleased with the continued strong level of interest from third parties for potential transactions, ranging from the sale of specific assets to consideration of Partnership-level transactions. We believe the strategic review process is entering advanced stages, and while there is no guarantee that any transaction will result from our strategic alternative review, we are making good progress narrowing the range of alternatives with the goal of maximizing value for the Partnership's unitholders. From a commercial perspective, we recently commissioned our DJ Basin de-bottlenecking projects, which will enable us to better utilize our processing complex and extract approximately $5 million of synergies in 2024. We commissioned the previously announced compression project behind our wholly owned Utica system, resulting in an incremental compression fee beginning in the first quarter of 2024. Further, our Ohio Gathering Joint Venture executed a new 25,500 acre dedication with a producer in the condensate window, illustrating the competitive positioning of our Joint Venture's gathering footprint in the Utica. At our Double E joint venture, we executed a new 40 MMcf/d 10-year take-or-pay contract with an investment grade shipper to support a connection to a new 300 MMcf/d processing plant three miles from the pipeline. With this new connection, we believe Double E is well positioned to commercialize additional contracts as volumes upstream of the new processing plant increase. We announced 2024 adjusted EBITDA guidance range of $260 million to $300 million, which we believe reflects the current headwinds, particularly in natural gas prices. Despite this volatility, we continue to see significant customer activity upstream of our assets with five rigs running behind our systems and remain encouraged with the long-term prospects for SMLP."
LE

Hot Stocks

06:47 EDT Land's End announces $25M share repurchase plan - Lands' End announced that its Board of Directors has authorized the repurchase of up to $25M of the company's common stock through March 31, 2026. The company's prior share repurchase authorization pursuant to which 2.3M shares were repurchased for an aggregate $20.3M beginning in June 2022, expired on February 2, 2024.
MRK

Hot Stocks

06:46 EDT Merck says Phase 3 KEYNOTE-A18 trial met primary endpoint - Merck announced that the Phase 3 KEYNOTE-A18 trial, also known as ENGOT-cx11/GOG-3047, investigating KEYTRUDA, Merck's anti-PD-1 therapy, in combination with chemoradiotherapy met its primary endpoint of overall survival for the treatment of newly diagnosed patients with high-risk locally advanced cervical cancer. At a pre-specified interim analysis conducted by an independent Data Monitoring Committee, KEYTRUDA in combination with concurrent CRT showed a statistically significant and clinically meaningful improvement in OS versus concurrent CRT alone. The safety profile of KEYTRUDA in this trial was consistent with that observed in previously reported studies; no new safety signals were identified. Results will be presented at an upcoming medical meeting and shared with regulatory authorities worldwide. "This is the first Phase 3 trial in which an immunotherapy-based regimen has shown a statistically significant and clinically meaningful improvement in overall survival compared to chemoradiotherapy alone," said Dr. Gursel Aktan, vice president, global clinical development, Merck Research Laboratories. "Building on the positive progression-free survival findings from this study, these results underscore our commitment to exploring the role of KEYTRUDA across different types of cancers in earlier stages of disease, where there is a greater potential for better outcomes."
HIBB

Hot Stocks

06:33 EDT Hibbett sees FY25 CapEx ~$65M-$75M - Sees FY25: Net store growth in units ~45-50; gross margin 34.2%-34.5%.
HITI

Hot Stocks

06:08 EDT High Tide to acquire Queen of Bud brand for $1M - High Tide announced that it is entering into a definitive agreement pursuant to which High Tide will acquire all IP, including trademarks and other assets of the Queen of Bud brand. Its founder, Ashley Newman, will take the role of global brand ambassador. This cannabis product portfolio is already available in Canada, and its ancillary products can be sold right now in the United States and Europe without having to rely on further legislative reforms. The transaction, which is an arm's length transaction, is subject to, among other things, receipt of the required approvals from the TSX Venture Exchange and the satisfaction of other customary conditions of closing. The transaction is expected to close in the coming weeks. The consideration for the assets acquired will be $1M. Of this amount, $100,000 will be paid in cash and the remaining will be paid in common shares of High Tide on the basis of a deemed price per High Tide Share equal to the 10-day volume weighted average price on the TSXV ending on the trading day that is three business days prior to the closing date, subject to a floor price equal to the Discounted Market Price as of the date this news release. The High Tide Shares will be subject to a contractual hold period of four months and one day from the date of closing.
QTI

Hot Stocks

06:06 EDT QT Imaging announces new ticker symbol for OTC warrants - QT Imaging updated the ticker symbol for its warrants to "QTIWW", currently trading in the over-the-counter market, effective as of March 11. The company's units formerly trading in the OTC market under "GIAFU" have been delisted as of March 11, as each unit was split into one share of common stock and one warrant upon the closing of its business combination on March 4.
TSQ

Hot Stocks

06:05 EDT Townsquare Media raises quarterly dividend 5.3% to 19.75c per share - The company announced that its Board of Directors approved a quarterly cash dividend of 19.75c per share. The dividend will be payable on May 1 to shareholders of record as of the close of business on April 5.
SOL

Hot Stocks

06:04 EDT Emeren, Glennmont to develop 155 MW of battery storage projects in Italy - Emeren announced the co-development agreement of 155 MW of Battery Storage Projects in two regions of Southern Italy with Glennmont Partners from Nuveen, one of the world's largest fund managers investing in clean energy. The partnership will involve Glennmont and Emeren jointly developing two stand-alone Battery Storage Projects in the Campania region of Southern Italy. As part of the transaction, Glennmont and Emeren will co-develop a project portfolio in Campania and Puglia with a combined capacity exceeding 150 MWp. These projects are scheduled to enter the construction stage in late 2025 and begin operations in early 2027.
BABA

Hot Stocks

05:51 EDT EU opens formal proceedings against AliExpress under DSA - The EU has opened formal proceedings to assess whether AliExpress may have breached the Digital Services Act in areas linked to the management and mitigation of risks, to content moderation and the internal complaint handling mechanism, to the transparency of advertising and recommender systems, to the traceability of traders and to data access for researchers. The commission will look at whether there was a lack of enforcement of AliExpress' own terms of service, which prohibit certain products that pose a risk for consumers' health, such as fake medicines. The probe will also focus on whether there were violations of the DSA that allowed minors to access pornographic material, which the commission said consumers can still find on the platform. Reference Link
META

Hot Stocks

05:48 EDT Meta to shut down CrowdTangle August 14 - Meta plans to shut down CrowdTangle in August and replace it with Meta Content Library, available to academic and nonprofit researchers, not news outlets. In an update on its website, Meta said "We let users know that CrowdTangle will no longer be available after August 14, 2024. This five-month notice period should give people time to complete any current projects they are using it for and, if eligible, to get up to speed with our new research tools, Meta Content Library and API, or others that serve their needs. People from qualified academic or nonprofit institutions who are pursuing scientific or public interest research can apply for access to these tools through the Inter-university Consortium for Political and Social Research at the University of Michigan. Meta Content Library and API are designed to give researchers access to comprehensive, publicly-accessible content across Facebook and Instagram. In April, researchers will be able to download publicly-accessible content posted by widely-known figures and organizations, and 'comments' will be added as a new data type within ICPSR's virtual clean room. We will continue to gather feedback from researchers and add new features and datasets over time." Reference Link
BMY

Hot Stocks

05:11 EDT Bristol Myers announces FDA grants accelerated approval of Breyanzi - Bristol Myers announced the FDA has granted accelerated approval of Breyanzi, a CD19-directed chimeric antigen receptor, or CAR, T cell therapy, for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia, or CLL, or small lymphocytic lymphoma, or SLL, who have received at least two prior lines of therapy, including a Bruton tyrosine kinase, or BTK, inhibitor and a B-cell lymphoma 2, or BCL-2, inhibitor. This indication is approved under accelerated approval based on response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial. In R/R CLL or SLL, Breyanzi is delivered through a treatment process which culminates in a one-time infusion* with a single dose containing 90 to 110 x 106 CAR-positive viable T cells. Please see the Important Safety Information section below, including Boxed WARNINGS for Breyanzi regarding Cytokine Release Syndrome, Neurologic Toxicities, and Secondary Hematological Malignancies.